Navigation Links
Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
Date:1/28/2010

====== ========
    
    
    The following table reconciles the specific items excluded from GAAP 
    operating expenses in the calculation of non-GAAP operating expenses for 
    the periods shown below:
    
                         THORATEC CORPORATION
         Reconciliation of GAAP to Non-GAAP Operating Expenses
                              (Unaudited)
                              (in thousands)
    
                          Three Months Ended   Twelve Months Ended
                          ------------------   -------------------
                          January    January   January   January
                             2,         3,        2,        3,
                            2010       2009      2010      2009
                            ----       ----      ----       ----
    
    Operating
     expenses on a
     GAAP basis           $41,431    $43,242   $172,817  $160,268
        Share-based
         compensation
         expense:
           -Selling,
            general and
            administrative (1,923)    (1,743)    (8,382)  (6,491)
           -Research and
            development      (801)      (690)    (3,492)  (2,626)
        Amortization of
         purchased
         intangibles       (2,596)    (3,296)   (10,663) (13,183)
        HeartWare
         transaction
         costs                 (1)         -    (12,314)       -
                              ---        ---    -------      ---
     Operating
      expenses on a
      non-GAAP
      basis                $36,110  $37,513    $137,966 $137,968
                           =======  =======    ======== ========
    
    
    
    
    
    The following table reconciles the specific items excluded from GAAP other
    income and expense in the calculation of non-GAAP other income and expense
    for the periods shown below:
    
                              THORATEC CORPORATION
           Reconciliation of GAAP to Non-GAAP Other Income and Expense
'/>"/>
SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
5. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
6. Thoratec Presentation at Canaccord Adams Conference to be Webcast
7. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
8. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
9. Thoratec Presentation at Piper Jaffray Conference to be Webcast
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Spherix Reports Second Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... t:slim® and t:flex™ Insulin Pumps, today announced the pricing ... its common stock at a price to the public ... from this offering are expected to be $56.3 million, ... offering expenses payable by Tandem. All of the shares ...
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... , Feb. 26, 2015  BD Life Sciences, a ... BDX ), a leading global medical ... focused on enabling high-resolution biology, today announced that ... for highly multiplexed cell isolation and single-cell gene ... BD,s powerful BD FACS™ single-cell sorting instrumentation and ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:Wireless Engineering Pioneer Joins NYU-Poly and NYU 2Wireless Engineering Pioneer Joins NYU-Poly and NYU 3Wireless Engineering Pioneer Joins NYU-Poly and NYU 4CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3
(Date:2/27/2015)... 27, 2015 Plugin creators from Pixel Film ... Final Cut Pro X. , “TransFold Volume 3 gives users ... FCPX users.” Said Christina Austin, CEO of Pixel Film ... Cut Pro X editor.” , TransFold Volume 3 comes packed ... The user can decide to change the shadow distance, opacity, ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 2015 Deep ... a professional and in-depth study on the current state ... a focus on the Chinese situation. , Major companies ... SHANGDONG ZOUPING, Hualun, Jiangsu Yuanyang, ZHENGZHOU TONGLI, Hebei ... and Jain & Jain. , The report provides a ...
(Date:2/26/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... says contains absolute proof that the bible can be trusted ... the plan, or purpose for mankind is. He says a ... beginning and an end. , “Yahweh has allotted 6,000 ... walk in His Righteousness, and who will not. Those who ...
(Date:2/26/2015)... Marking its fifth successful year of business, UV ... the development of a new and improved UV-Aid light supplement ... spring. UV-Aid is a unique and patent pending technology that ... areas of the body susceptible to infection. UVA light has ... daily dose of UV-Aid is equivalent to less than a ...
(Date:2/26/2015)... 2015 Healthpointe is proud to ... Dr. Neil Thomas Katz, MD, is now offering ... throughout Southern California, including Long Beach , ... and fellowship-trained to provide quality care, and specializes ... Neil Katz provides surgical and non-surgical treatments for ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 3Health News:Yisrayl Hawkins Says There is Only One Place Shown in Scripture to Achieve Salvation and Shows Proof in New Letter 2Health News:UV Technologies, LLC Developing New More Effective UV-Aid for Flu and Cold Prevention 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 3
... found that Salmonella bacteria found in garden birds are ... the bacteria found in livestock and humans. , Salmonella ... undetected in animals, which increases the risk of the ... strains found in birds in the laboratory and found ...
... of NSCLC, CHICAGO, June 2 Exelixis, Inc. ... of XL647, a novel small molecule,inhibitor of EGFR, HER2, ... Society of Clinical Oncology (ASCO). Updated data from an ... cell,lung cancer (NSCLC) patients show encouraging anti-tumor activity of ...
... NEW YORK, June 2 American Oriental,Bioengineering (NYSE: ... of Directors has,authorized a share repurchase program for ... Company,s outstanding common stock., Purchases under this ... in the,open market, privately negotiated transactions, and accelerated ...
... Pain Patients with Substance ... Use Disorders WHO: ... 4th - 6th, ... pm, PHILADELPHIA, June 2 Valley Forge Medical Center and,Hospital is the first facility on ...
... with a combination of chemotherapy, biotherapy and radiotherapy prior ... patients, according to a University of Pittsburgh Cancer Institute ... the American Society of Clinical Oncology (ASCO) in Chicago. ... Cancer Center of the University of Pittsburgh Medical Center ...
... CO June 2, 2008 Results from an ... and lost time among employees suffering from multiple sclerosis ... were presented and announced by Biogen Idec as poster ... annual meeting in Denver, Colorado, May 28-May 31, 2008. ...
Cached Medicine News:Health News:Salmonella in garden birds responsive to antibiotics 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:American Oriental Bioengineering Announces US$75 Million Share Repurchase Program 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:New treatment combination safe for pancreatic cancer patients 2Health News:New data show patients using avonex reported less sick leave and short-term disability costs 2
... is a standard gelling temperature, high gel ... than 1,000 bp. This Genetic Technology Grade™ ... DNA electrophoresis. DNA recovered from SeaKem GTG ... ligated. SeaKem GTG Agarose is extensively performance ...
... is recommended for separations of DNA fragments ... that are easy to handle, and remains ... minimizes the risk of cracking or breaking. ... (GQT) products with similar sieving properties, is ...
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... PK7200 works on patented microplate agglutination ... testing system for donor ABO/Rh testing. PK7200 ... syphilis and cytomegalovirus antibody detection. The Automated ... along with the proven reliability that for ...
Medicine Products: